iTeos Therapeutics, Inc. Annual Revenues in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
iTeos Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2021 to 2023.
  • iTeos Therapeutics, Inc. Revenues for the quarter ending September 30, 2024 was $0.000.
  • iTeos Therapeutics, Inc. Revenues for the twelve months ending September 30, 2024 was $35M, a 47.4% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Revenues for 2023 was $12.6M, a 95.3% decline from 2022.
  • iTeos Therapeutics, Inc. annual Revenues for 2022 was $268M, a 22.4% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.6M -$255M -95.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $268M -$77.1M -22.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $345M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.